9:30 a.m.
Labor, Commerce, Research and Economic Development Committee; public hearings; room 208; Cross Building
L.D. 1288, "An Act Regarding Impairment of Health of a Correctional Employee Caused by Infectious Disease": provides that a condition of impairment of health caused by an infectious disease resulting in total or partial disability or death of an employee of a correctional facility must be presumed to have been received in the line of duty, unless the contrary is shown by competent evidence.
L.D. 1315, "An Act To Ensure the Safety of Compounded Drugs": defines "compounding pharmacy" and describes sterile and nonsterile compounding pharmacies; to the Maine Board of Pharmacy adds a physician and advanced practice registered nurse, decreases the number of pharmacists to three and requires that one public member has education and professional experience in the field of health care safety and quality assurance; requires compounding pharmacies to obtain a license as such and to specify if they are sterile or nonsterile; includes in the Maine Board of Pharmacy responsibilities licensing out-of-state compounding pharmacies, appoint and convene advisory committees, impose a fine on compounding pharmacies that violate the Maine Pharmacy Act, participate in data reporting and license pharmacy technicians in two categories: sterile and nonsterile; allows the board consultations with the Board of Licensure in Medicine, the Board of Osteopathic Licensure and the commissioner of Health and Human Services regarding the compounding of drugs; requires the Maine Board of Pharmacy to ensure standards for purity and quality are met by compounding pharmacies; adds documentation regarding compounding to the list of items that the board may remove from a premises being inspected; requires that licensing fees for pharmacies distinguish between compounding, sterile compounding and nonsterile compounding pharmacies; adds sterile and nonsterile compounding of drugs course work for continuing education for pharmacists; requires the Department of Health and Human Services to adopt rules regarding compounding pharmacies in hospitals and nursing facilities; and requires the director of Maine Center for Disease Control and Prevention to consult with the Maine Board of Pharmacy on issues related to epidemiology and public health.
Source found here
No comments:
Post a Comment